Pharmacokinetics of Triferic (Ferric Pyrophosphate Citrate) Administered Via Dialysate and IV to Pediatric Patients on Chronic Hemodialysis
Phase of Trial: Phase I/II
Latest Information Update: 30 Oct 2017
At a glance
- Drugs Ferric pyrophosphate (Primary)
- Indications Iron deficiency anaemia
- Focus Pharmacokinetics
- Sponsors Rockwell Medical Technologies
- 30 Oct 2017 According to a Rockwell Medical India media release, data from the study will be presented at the American Society of Nephrology Kidney Week 2017 Annual Meeting.
- 18 Jan 2017 Status changed from recruiting to completed.
- 11 Oct 2016 Planned End Date changed from 1 Sep 2016 to 1 Nov 2016.